Anavex Life Sciences Corp (AVXL)

[falconer66a]

Things Coming Together for Anavex and Blarcamesine

So, as a first step in getting blarcamesine approved for sale and use in Europe, Anavex has opened exploratory discussions with the European Medicines Agency (EMA), the European equivalent of the Food and Drug Administration (FDA) in the US.

Might this, then, portend a similar maneuver soon to follow, Down Under, in Australia?

Soon enough, blarcamesine for Alzheimer’s can be in regulatory consideration in three major pharmaceutical markets, Europe, the US, and Australia.

Then, in the middle of all of this will be the promised appearance of a confirmatory article on the efficacy and safety of blarcamesine in a clinical trail(s) report in a major peer-reviewed medical journal.

Getting ever more entertaining to read the ever more vacuous postings of the Anavex naysayers. When blarcamesine gets approved somewhere and people with Alzheimer’s start getting improved sleep and cognition, there will be helpful postings that the drug is actually a toxin and everyone taking it will die. ‘Big mistake. We know better. Should never have been approved....’